Wamberg Genomic Advisors Executive VP, Sales & Business Development Nick Bellanca talks with Leader’s Edge Magazine about genetic products and services as part of employer benefit packages.
In January 2019 Think Advisor published an article about how Wamberg Genomic Advisors and Cancer Guardian are demonstrating that “life insurers, brokers and employers could be good markets for tumor profile test benefits.”
“Tom Wamberg, the company’s chief executive officer, talked about his company during a recent interview in New York. Wamberg attended a LIMRA conference in an effort to persuade life insurers to add the company’s Cancer Guardian service package as a standard or add-on feature.”
“‘This is a tidal wave that’s coming,’ Wamberg said.”
Wamberg Genomic Advisors was mentioned in the January 14-20, 2019 issue of the San Diego Business Journal, in the cover article, CATCHING UP TO CARE.
“Genomics bleeding into insurance has given rise to firms with a foot in both worlds. Wamberg Genomic Advisors in La Jolla is one.
‘We found there was a need to interpret for both industries,’ said CEO Tom Wamberg.
The company specializes in employer genomic programs, not typically covered by health insurance. It also works with life insurers, some of which see genome sequencing as a means to extend life — and thus good for business.”